R&D The reasoning problem In R&D, decisions that matter most rarely happen during the documented steps; they happen in the pauses between them.
Patients Overseas doctors are keeping the NHS alive: It’s time we sto... As a loud minority pushes Britain towards devolved nationalism, it’s worth remembering this sobering truth: without immigrants, there would be no NHS.
R&D Changing Faces: Pharma and biotech November-December 2024 Welcome to the last edition of Changing Faces for 2024.
Sales & Marketing Revitalising life sciences hiring: The case for creative rec... The labour market in the life sciences sector has stabilised, but employers are still finding it challenging to attract the best talent.
Market Access Balancing innovation and safety: The impact of Medtech regul... The Medtech sector is currently at a crossroads, facing a potential choice between rapid technological advancement and strict regulatory oversight.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires from... Another light month in March on the agency and investor side, but there are a few appointments worth noting.
News Sanofi to lay off 229 Blueprint employees, close offices A year after its $9.1bn acquisition of Blueprint Medicines, Sanofi is moving out of Blueprint's Cambridge, MA offices and letting 229 employees go.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
